Achieving durable compliance with venous thromboembolism prophylaxis in bariatric surgery : 3-year data from a major academic medical center
Copyright © 2024 American Society for Metabolic and Bariatric Surgery. Published by Elsevier Inc. All rights reserved..
BACKGROUND: Metabolic and bariatric surgery (MBS) venous thromboembolism (VTE) prescribing practices vary widely. Our institutional VTE prophylaxis protocol has historically been unstandardized.
OBJECTIVES: To create a standardized MBS VTE prophylaxis protocol, track protocol compliance, and identify barriers to protocol compliance and address them with Plan-Do-Study-Act (PDSA) cycles.
SETTING: Single Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program-accredited academic hospital.
METHODS: We conducted a retrospective study for all patients undergoing MBS (January 2019 to September 2022). A multidisciplinary group of bariatric clinicians reviewed literature and developed the following standardized VTE prophylaxis protocol: 5000 units preoperative subcutaneous (SC) heparin within 60 minutes of anesthesia induction and postoperative 40 mg SC low molecular weight heparin (LMWH) within 24 hours of surgery. This protocol was distributed to relevant clinical stakeholders. We assessed monthly compliance rates through chart review. Goal compliance was ≥90%. We identified sources of noncompliance and addressed them with PDSA methodology.
RESULTS: A total of 796 patients were included. Preoperative heparin administration increased from a mean of 47% (107/228) preintervention to 96% (545/568) postintervention (P < .0001), and postoperative LMWH administration increased from 71% (47/66) to 96% (573/597, P = .0002). These compliance rates were sustained for 3 years. Barriers to protocol noncompliance included order set timing errors (n = 45), surgeon error (n = 44), surgeon discretion (n = 40), and nursing error (n = 20). No change in bleeding or VTE rates was observed.
CONCLUSIONS: Developing a standardized VTE prophylaxis protocol, monitoring process measures, and engaging relevant stakeholders in PDSA cycles resulted in drastic and durable improvement in VTE prophylaxis compliance rates.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 2023 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery - 20(2023), 1 vom: 01. Jan., Seite 72-79 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mou, Danny [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
9005-49-6 |
|---|
| Anmerkungen: |
Date Completed 22.12.2023 Date Revised 22.12.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.soard.2023.08.008 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361817150 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361817150 | ||
| 003 | DE-627 | ||
| 005 | 20231227135855.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.soard.2023.08.008 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1235.xml |
| 035 | |a (DE-627)NLM361817150 | ||
| 035 | |a (NLM)37684191 | ||
| 035 | |a (PII)S1550-7289(23)00628-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mou, Danny |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Achieving durable compliance with venous thromboembolism prophylaxis in bariatric surgery |b 3-year data from a major academic medical center |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.12.2023 | ||
| 500 | |a Date Revised 22.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 American Society for Metabolic and Bariatric Surgery. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a BACKGROUND: Metabolic and bariatric surgery (MBS) venous thromboembolism (VTE) prescribing practices vary widely. Our institutional VTE prophylaxis protocol has historically been unstandardized | ||
| 520 | |a OBJECTIVES: To create a standardized MBS VTE prophylaxis protocol, track protocol compliance, and identify barriers to protocol compliance and address them with Plan-Do-Study-Act (PDSA) cycles | ||
| 520 | |a SETTING: Single Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program-accredited academic hospital | ||
| 520 | |a METHODS: We conducted a retrospective study for all patients undergoing MBS (January 2019 to September 2022). A multidisciplinary group of bariatric clinicians reviewed literature and developed the following standardized VTE prophylaxis protocol: 5000 units preoperative subcutaneous (SC) heparin within 60 minutes of anesthesia induction and postoperative 40 mg SC low molecular weight heparin (LMWH) within 24 hours of surgery. This protocol was distributed to relevant clinical stakeholders. We assessed monthly compliance rates through chart review. Goal compliance was ≥90%. We identified sources of noncompliance and addressed them with PDSA methodology | ||
| 520 | |a RESULTS: A total of 796 patients were included. Preoperative heparin administration increased from a mean of 47% (107/228) preintervention to 96% (545/568) postintervention (P < .0001), and postoperative LMWH administration increased from 71% (47/66) to 96% (573/597, P = .0002). These compliance rates were sustained for 3 years. Barriers to protocol noncompliance included order set timing errors (n = 45), surgeon error (n = 44), surgeon discretion (n = 40), and nursing error (n = 20). No change in bleeding or VTE rates was observed | ||
| 520 | |a CONCLUSIONS: Developing a standardized VTE prophylaxis protocol, monitoring process measures, and engaging relevant stakeholders in PDSA cycles resulted in drastic and durable improvement in VTE prophylaxis compliance rates | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Bariatric surgery | |
| 650 | 4 | |a Compliance | |
| 650 | 4 | |a Pulmonary embolus | |
| 650 | 4 | |a Quality improvement | |
| 650 | 4 | |a Venous thromboembolism prophylaxis | |
| 650 | 7 | |a Heparin, Low-Molecular-Weight |2 NLM | |
| 650 | 7 | |a Anticoagulants |2 NLM | |
| 650 | 7 | |a Heparin |2 NLM | |
| 650 | 7 | |a 9005-49-6 |2 NLM | |
| 700 | 1 | |a Falconer, Elissa |e verfasserin |4 aut | |
| 700 | 1 | |a Majumdar, Melissa |e verfasserin |4 aut | |
| 700 | 1 | |a Delgado, Tori |e verfasserin |4 aut | |
| 700 | 1 | |a Fay, Katherine |e verfasserin |4 aut | |
| 700 | 1 | |a Hall, Carrie E |e verfasserin |4 aut | |
| 700 | 1 | |a Smach, Carla |e verfasserin |4 aut | |
| 700 | 1 | |a Ashraf, Shanza |e verfasserin |4 aut | |
| 700 | 1 | |a Levett, Sydnee |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Edward |e verfasserin |4 aut | |
| 700 | 1 | |a Davis, Scott |e verfasserin |4 aut | |
| 700 | 1 | |a Patel, Ankit |e verfasserin |4 aut | |
| 700 | 1 | |a Stetler, Jamil |e verfasserin |4 aut | |
| 700 | 1 | |a Serrot, Federico |e verfasserin |4 aut | |
| 700 | 1 | |a Srinivasan, Jahnavi |e verfasserin |4 aut | |
| 700 | 1 | |a Oyefule, Omobolanle |e verfasserin |4 aut | |
| 700 | 1 | |a Diller, Maggie |e verfasserin |4 aut | |
| 700 | 1 | |a Hechenbleikner, Elizabeth |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery |d 2005 |g 20(2023), 1 vom: 01. Jan., Seite 72-79 |w (DE-627)NLM16493006X |x 1878-7533 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2023 |g number:1 |g day:01 |g month:01 |g pages:72-79 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.soard.2023.08.008 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2023 |e 1 |b 01 |c 01 |h 72-79 | ||